Damora Therapeutics is focused on mutant-CALR blood diseases, with DMR-001 as its lead asset. Find out why DMRA stock is a ...

Chief Medical Officer Steven Stein outlined the company’s development priorities across hematology, oncology and immunology, ...

RBC Capital Markets Global Healthcare Conference 2026 May 19, 2026 10:30 AM EDTCompany ParticipantsSteven Stein - Executive ...

Key Points Interested in Incyte Corporation? Here are five stocks we like better. Incyte's CEO says the company's post-Jakafi ...

WILMINGTON, Del., May 12, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today reported its financial results for the first ...

DMR-001 preclinical data showcasing potentially best-in-class potency, half-life and anti-mutCALR activity to be presented at 2026 European ...

Tracking how blood cancers develop over time has uncovered important genetic differences between patients whose disease stays stable while others worsen. The research also reveals how genetic ...

A newly identified gene mutation may help explain why schizophrenia patients struggle to update their understanding of reality. The mutation disrupts a brain circuit involved in flexible ...

Krista McCay is a writer specializing in video game guides and walkthroughs. She first entered the industry in 2022 while studying English at UC Santa Barbara and working part-time as an editor. It ...

Risk stratification replaces “Stage 4” terminology, prioritizing prevention of arterial/venous thrombosis and bleeding events over tumor burden concepts. Diagnostic confirmation typically integrates ...

An estimated 170,000 Australians were diagnosed with cancer in 2025. Many people know the causes of cancer are partly genetic. But how do your genes, which contribute so much of what makes you you, ...